Addus HomeCare (NASDAQ:ADUS) Announces Quarterly Earnings Results, Beats Expectations By $0.24 EPS

Addus HomeCare (NASDAQ:ADUS) issued its quarterly earnings data on Monday. The company reported $1.21 earnings per share for the quarter, beating the consensus estimate of $0.97 by $0.24, Briefing.com reports. Addus HomeCare had a return on equity of 9.70% and a net margin of 5.91%. The business had revenue of $280.70 million for the quarter, compared to analysts’ expectations of $279.49 million. During the same period last year, the business earned $0.84 EPS. The business’s revenue was up 11.6% on a year-over-year basis.

Addus HomeCare Stock Performance

Shares of ADUS stock opened at $107.09 on Thursday. The firm’s 50 day moving average is $99.03 and its 200 day moving average is $92.71. The company has a current ratio of 1.38, a quick ratio of 1.38 and a debt-to-equity ratio of 0.18. Addus HomeCare has a 12 month low of $78.35 and a 12 month high of $107.54. The stock has a market capitalization of $1.75 billion, a P/E ratio of 26.57, a PEG ratio of 1.94 and a beta of 0.96.

Wall Street Analyst Weigh In

ADUS has been the topic of several analyst reports. Bank of America boosted their price target on shares of Addus HomeCare from $115.00 to $118.00 and gave the stock a “buy” rating in a report on Tuesday. Royal Bank of Canada reaffirmed an “outperform” rating and set a $102.00 price target on shares of Addus HomeCare in a research report on Thursday, February 29th. William Blair restated an “outperform” rating on shares of Addus HomeCare in a research note on Monday, February 5th. Barclays cut Addus HomeCare from an “equal weight” rating to an “underweight” rating and set a $83.00 target price on the stock. in a research note on Tuesday, April 23rd. Finally, Stephens restated an “overweight” rating and set a $115.00 price objective on shares of Addus HomeCare in a report on Tuesday. One analyst has rated the stock with a sell rating and eight have issued a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $106.57.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.